Reuters logo
BRIEF-Biostage says provides regulatory update of Cellspan Esophageal Implant
October 6, 2016 / 8:22 PM / in a year

BRIEF-Biostage says provides regulatory update of Cellspan Esophageal Implant

Oct 6 (Reuters) - Biostage Inc

* Biostage management has determined that it will extend duration of ongoing GLP animal studies

* Biostage provides regulatory update of Cellspan Esophageal Implant

* Expects to file its ind application with FDA by end of Q2 of 2017

* FDA requested that company extend its pre-clinical large-animal safety study for its Cellspan Esophageal Implant Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below